Hydrops Fetalis Associated with Fetal Hemoglobin H-Pakse Disease.


Journal

Fetal diagnosis and therapy
ISSN: 1421-9964
Titre abrégé: Fetal Diagn Ther
Pays: Switzerland
ID NLM: 9107463

Informations de publication

Date de publication:
2022
Historique:
received: 26 07 2022
accepted: 26 11 2022
pubmed: 28 12 2022
medline: 3 3 2023
entrez: 27 12 2022
Statut: ppublish

Résumé

Hemoglobin H-Pakse (Hb H-PS) disease is a variant of non-deletional Hb H disease associated with various degrees of anemia. The disorder is rare but commonly seen in Southeast Asia. However, the prenatal course of Hb H-PS disease has never been published. The objective of this report was to describe prenatal diagnosis and management of Hb H-PS disease, which is theoretically much more critical in fetal life than adult life. The prenatal courses of two fetuses affected by Hb H-PS were comprehensively explored. Both of them showed sonographic signs of fetal anemia at 19-20 weeks of gestation (increased cardiac size and increase middle cerebral artery peak systolic velocity [MCA-PSV]). On follow-up scans, both revealed frank hydropic signs at 22-24 weeks. One fetus died at 24 weeks, shortly before the scheduled intrauterine blood transfusion (IUT). The other one underwent IUT at 22 weeks, leading to completely reversed hydropic signs, which resulted in successful outcomes that ended with the delivery of a healthy baby at term. The fetus needed only one IUT, and the course of anemic status improved in late pregnancy. IUT in this case was possibly beneficial to adult life. Fetuses with Hb H-PS may be associated with hydrops fetalis, usually occurring at mid-pregnancy. The hydrops tends to improve in late gestation. If they can pass through this most critical period in utero without anemic insults in developing organs, good long-term prognosis can be expected. This successful prenatal diagnosis and intrauterine treatment may encourage care providers to pay more attention to fetal Hb H-PS disease, to prevent anemic hypoxia in developing organs and adult diseases of fetal origin.

Identifiants

pubmed: 36574766
pii: 000528510
doi: 10.1159/000528510
doi:

Substances chimiques

Fetal Hemoglobin 9034-63-3

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

528-535

Informations de copyright

© 2022 S. Karger AG, Basel.

Auteurs

Suchaya Luewan (S)

Department of Obstetrics and Gynecology, Chiang Mai University, Chiang Mai, Thailand.
Thalassemia and Hematology Center, Chiang Mai, Thailand.

Supatra Sirichotiyakul (S)

Department of Obstetrics and Gynecology, Chiang Mai University, Chiang Mai, Thailand.
Thalassemia and Hematology Center, Chiang Mai, Thailand.

Pimlak Charoenkwan (P)

Thalassemia and Hematology Center, Chiang Mai, Thailand.
Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Krittaya Phirom (K)

Department of Obstetrics and Gynecology, Chiang Mai University, Chiang Mai, Thailand.

Theera Tongsong (T)

Department of Obstetrics and Gynecology, Chiang Mai University, Chiang Mai, Thailand.
Thalassemia and Hematology Center, Chiang Mai, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH